{
    "nctId": "NCT03847220",
    "briefTitle": "Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis",
    "officialTitle": "Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma Metastatic to the Bone",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 241,
    "primaryOutcomeMeasure": "Impact on the HRQoL",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient over 18 years of age.\n* Patient diagnosed with BC and BM.\n* Patient who has granted informed consent in writing to participate in the study.\n* Patient capable of understanding and completing the questionnaires\n\nExclusion Criteria:\n\n* Patient with another type of disease that, in the investigator's opinion, could mask the study results.\n* Patients with a life expectancy of less than 8 months.\n* Patient who is participating in a clinical trial with an unregistered drug at the start of the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}